ASHP and the co-conveners of the 2011 Drug Shortages Summit, the American Hospital Association (AHA), the American Society of Anesthesiologists (ASA), the American Society of Clinical Oncology (ASCO), , and the Institute for Safe Medication Practices (ISMP) met last week to touch base on their ongoing efforts to address drug shortages.
Meeting attendees discussed the status of implementing the Food and Drug Administration Safety and Innovation Act (FDASIA), which was passed last year to address the ongoing drug shortages crisis. Representatives from the FDA were on hand to discuss the strategic plan and task force on drug shortages that were mandated by the legislation. FDA officials noted that the early warning requirements included in FDASIA have helped the agency prevent new shortages and better manage existing ones.
The meeting also served as a platform to explore further solutions to the drug shortage problem like exploring redundancies and other manufacturer incentives, working with the FDA task force to prevent and mitigate shortages, and the industry-sponsored accelerated recovery initiative, which is designed to gauge manufacturing capacity to anticipate potential shortage situations.
Also participating in the meeting were representatives from the American Medical Association, the American Society for Parenteral and Enteral Nutrition, the Centers for Disease Control and Prevention, the Children’s Hospital Association, the Generic Pharmaceutical Association, the Healthcare Distribution Management Association, the Healthcare Supply Chain Association, Hospira, group purchasing organizations Premier and MedAssets, and Westward Pharmaceuticals.